Pasithea Therapeutics (KTTA) Corporate Presentation from NobleCon18News and Market Data on Pasithea TherapeuticsNobleCon 18 Complete Rebroadcast
|
Access to Exclusive Content. FREE for Registered Users Only.
Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost.
‌


Welcome to the Channelchek Investor Community
We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.
Don't have an account? Join
Forgot passwordBy clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.
Related News
‌


5/2/2025
Health
Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results
MALVERN, Pa., May 02, 2025 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it...
3 min read
‌


5/2/2025
Media and Entertainment
Cumulus Media (CMLS) – Skating On Thin Ice
Q1 revenue weaker than expected. Total company revenues declined 6.4% to $187.3 million, weaker than our 4.8% decline and $190.4 million estimates, respectively. Due to previous cost reductions, the company achieved...
2 min read
‌


5/2/2025
Consumer
Xcel Brands (XELB) – Keeping Its Focus On The Bullseye
Collaboration with a UTG. United Trademark Group (UTG) made a $9 million strategic investment in Xcel Brands and announced a strategic partnership. The investment bolstered the company’s balance sheet and provided...
2 min read
Inbox Intel from Channelchek.
Informed investors make more money. And it’s all about timing. Get it when it happens.